**Core Concept**
Linaclotide is a medication used to treat constipation-predominant irritable bowel syndrome (IBS-C) and chronic idiopathic constipation (CIC). It works by activating the guanylate cyclase-C receptor in the gastrointestinal tract, leading to increased intestinal fluid secretion and accelerated intestinal transit.

**Why the Correct Answer is Right**
Linaclotide is a guanylate cyclase-C agonist. Upon binding to the guanylate cyclase-C receptor, it activates the enzyme, which in turn increases the production of cyclic guanosine monophosphate (cGMP). Elevated cGMP levels stimulate the secretion of chloride and bicarbonate ions into the intestinal lumen, resulting in increased intestinal fluid and accelerated bowel movements. This mechanism bypasses the neural pathways that regulate bowel movements, making it an effective treatment for constipation-predominant IBS-C and CIC.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the mechanism of action of linaclotide.
**Option B:** This option is incorrect because it is associated with a different class of medications that work through a different mechanism of action.
**Option C:** This option is incorrect because it is associated with a different type of medication that is not a guanylate cyclase-C agonist.

**Clinical Pearl / High-Yield Fact**
Linaclotide is a first-in-class medication that has revolutionized the treatment of constipation-predominant IBS-C and CIC. Its unique mechanism of action makes it an attractive option for patients who have failed other treatments.

**Correct Answer: C. Guanylate cyclase-C agonist.